메뉴 건너뛰기




Volumn 29, Issue 3, 1999, Pages 924-927

Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PLACEBO; RECOMBINANT VACCINE;

EID: 0033020623     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290327     Document Type: Article
Times cited : (69)

References (9)
  • 1
    • 0004683041 scopus 로고    scopus 로고
    • Geneva, Switzerland
    • WHO Report 1996, Geneva, Switzerland.
    • WHO Report 1996
  • 2
    • 0027471994 scopus 로고
    • Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis
    • Krahn M, Detsky AS. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis. Med Decis Making 1993;13:4-20.
    • (1993) Med Decis Making , vol.13 , pp. 4-20
    • Krahn, M.1    Detsky, A.S.2
  • 3
    • 0003192550 scopus 로고
    • Protection against viral hepatitis
    • Centers for Disease Control. Protection against viral hepatitis. MMWR 1990:39:1-26.
    • (1990) MMWR , vol.39 , pp. 1-26
  • 4
    • 0019864763 scopus 로고
    • A controlled clinical trial of the efficacy of hepatitis B vaccine (Heptavax B): A final report
    • Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of hepatitis B vaccine (Heptavax B): a final report. HEPATOLOGY 1981;1:377-385.
    • (1981) Hepatology , vol.1 , pp. 377-385
    • Szmuness, W.1    Stevens, C.E.2    Zang, E.A.3    Harley, E.J.4    Kellner, A.5
  • 5
    • 0027682677 scopus 로고
    • Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responses
    • Lai CL, Wong BCY, Yeoh EK, Lim WL, Chang WK, Lin HJ. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses. HEPATOLOGY 1993;18:763-767.
    • (1993) Hepatology , vol.18 , pp. 763-767
    • Lai, C.L.1    Wong, B.C.Y.2    Yeoh, E.K.3    Lim, W.L.4    Chang, W.K.5    Lin, H.J.6
  • 7
    • 0024576864 scopus 로고
    • Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response
    • Wismans PJ, Hattum V, Mudde GC, Endeman HJ, Pocl J, deGast GC. Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol 1989;8:236-240.
    • (1989) J Hepatol , vol.8 , pp. 236-240
    • Wismans, P.J.1    Hattum, V.2    Mudde, G.C.3    Endeman, H.J.4    Pocl, J.5    DeGast, G.C.6
  • 8
    • 0023038754 scopus 로고
    • Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal)
    • Coursaget P, Yvonnet B, Chotard J, Sarr M, Vincelot P, N'doye R, Diop Mar I, et al. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986;2:1143-1145.
    • (1986) Lancet , vol.2 , pp. 1143-1145
    • Coursaget, P.1    Yvonnet, B.2    Chotard, J.3    Sarr, M.4    Vincelot, P.5    N'Doye, R.6    Diop Mar, I.7
  • 9
    • 0027998121 scopus 로고
    • Hepatitis B vaccination in children: Persistence of immunity at 9 years
    • Milne A, Hopkirk N, Moyes CD. Hepatitis B vaccination in children: persistence of immunity at 9 years. J Med Virol 1994;44:113-114.
    • (1994) J Med Virol , vol.44 , pp. 113-114
    • Milne, A.1    Hopkirk, N.2    Moyes, C.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.